Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy.

Medical review (Berlin, Germany) Pub Date : 2022-04-26 Epub Date: 2022-04-28 DOI:10.1515/mr-2021-0024
Zhaomin Feng, Yi Zhang, Yang Pan, Daitao Zhang, Lei Zhang, Quanyi Wang
{"title":"Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy.","authors":"Zhaomin Feng,&nbsp;Yi Zhang,&nbsp;Yang Pan,&nbsp;Daitao Zhang,&nbsp;Lei Zhang,&nbsp;Quanyi Wang","doi":"10.1515/mr-2021-0024","DOIUrl":null,"url":null,"abstract":"<p><p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":" ","pages":"197-212"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/f8/mr-2-2-mr-2021-0024.PMC9274759.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical review (Berlin, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/mr-2021-0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly.

Abstract Image

Abstract Image

Abstract Image

大规模筛查是抗击新冠病毒和恢复正常的关键组成部分。
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)具有高度传染性和致病性,造成了严重的经济损失和公共卫生危害。不同国家制定了符合其流行病学情况、能力和价值观的应对COVID-19大流行战略。大规模筛查结合控制措施迅速减少了SARS-CoV-2感染的传播。2019冠状病毒病大流行极大地突出了诊断能力在控制传染病方面的重要作用。大规模筛查越来越多地用于发现新冠肺炎疑似病例及其密切接触者、无症状病例、发热门诊患者、高危人群、员工,甚至所有人群,以识别感染个体。大规模筛查是抗击新冠病毒和恢复正常的关键组成部分。本文介绍了大规模筛查的历史,界定了大规模筛查的范围,描述了大规模筛查的应用场景,并讨论了使用这种方法控制新冠肺炎的影响和挑战。我们的结论是,通过全面的筛查计划和强大的检测能力,大规模筛查可以帮助我们更快地恢复正常。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信